Cardax Inc (CDXI)
0.00
USD |
OTCM |
May 16, 16:00
Cardax Cash from Financing (TTM): 1.574M for March 31, 2021
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2021 | 1.574M |
December 31, 2020 | 1.806M |
September 30, 2020 | 1.997M |
June 30, 2020 | 2.511M |
March 31, 2020 | 2.925M |
December 31, 2019 | 3.36M |
September 30, 2019 | 3.410M |
June 30, 2019 | 3.114M |
March 31, 2019 | 2.289M |
December 31, 2018 | 1.244M |
September 30, 2018 | 0.8294M |
June 30, 2018 | 3.596M |
March 31, 2018 | 3.889M |
December 31, 2017 | 4.178M |
September 30, 2017 | 4.374M |
June 30, 2017 | 1.14M |
March 31, 2017 | 1.41M |
Date | Value |
---|---|
December 31, 2016 | 1.121M |
September 30, 2016 | 1.146M |
June 30, 2016 | 1.244M |
March 31, 2016 | 1.411M |
December 31, 2015 | 1.806M |
September 30, 2015 | 1.46M |
June 30, 2015 | 1.126M |
March 31, 2015 | 0.3957M |
December 31, 2014 | 5.449M |
September 30, 2014 | 5.449M |
June 30, 2014 | 5.459M |
March 31, 2014 | 5.459M |
December 31, 2013 | 0.0149M |
September 30, 2013 | 0.0262M |
June 30, 2013 | 0.0163M |
March 31, 2013 | 0.0161M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.574M
Minimum
Mar 2021
3.410M
Maximum
Sep 2019
2.587M
Average
2.718M
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.313M |
Palatin Technologies Inc | 14.71M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.68M |
Oragenics Inc | 0.2839M |